Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line

Identifieur interne : 003753 ( PascalFrancis/Checkpoint ); précédent : 003752; suivant : 003754

Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line

Auteurs : B. Pardo [États-Unis] ; M. A. Mena [États-Unis] ; S. Fahn ; J. Garcia De Yebenes

Source :

RBID : Pascal:93-0595131

Descripteurs français

English descriptors


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:93-0595131

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line</title>
<author>
<name sortKey="Pardo, B" sort="Pardo, B" uniqKey="Pardo B" first="B." last="Pardo">B. Pardo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Cent. Ramón y Cajal', dep. res.</s1>
<s2>Madrid 28404</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Madrid 28404</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mena, M A" sort="Mena, M A" uniqKey="Mena M" first="M. A." last="Mena">M. A. Mena</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Cent. Ramón y Cajal', dep. res.</s1>
<s2>Madrid 28404</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Madrid 28404</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fahn, S" sort="Fahn, S" uniqKey="Fahn S" first="S." last="Fahn">S. Fahn</name>
</author>
<author>
<name sortKey="Garcia De Yebenes, J" sort="Garcia De Yebenes, J" uniqKey="Garcia De Yebenes J" first="J." last="Garcia De Yebenes">J. Garcia De Yebenes</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">93-0595131</idno>
<date when="1993">1993</date>
<idno type="stanalyst">PASCAL 93-0595131 INIST</idno>
<idno type="RBID">Pascal:93-0595131</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003717</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003107</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">003753</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line</title>
<author>
<name sortKey="Pardo, B" sort="Pardo, B" uniqKey="Pardo B" first="B." last="Pardo">B. Pardo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Cent. Ramón y Cajal', dep. res.</s1>
<s2>Madrid 28404</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Madrid 28404</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mena, M A" sort="Mena, M A" uniqKey="Mena M" first="M. A." last="Mena">M. A. Mena</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Cent. Ramón y Cajal', dep. res.</s1>
<s2>Madrid 28404</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Madrid 28404</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fahn, S" sort="Fahn, S" uniqKey="Fahn S" first="S." last="Fahn">S. Fahn</name>
</author>
<author>
<name sortKey="Garcia De Yebenes, J" sort="Garcia De Yebenes, J" uniqKey="Garcia De Yebenes J" first="J." last="Garcia De Yebenes">J. Garcia De Yebenes</name>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="1993">1993</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiparkinson agent</term>
<term>Ascorbic acid</term>
<term>Cell culture</term>
<term>Dopa</term>
<term>Human</term>
<term>Neuroblastoma</term>
<term>Prevention</term>
<term>Toxicity</term>
<term>Tumor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Tumeur</term>
<term>Prévention</term>
<term>Toxicité</term>
<term>Homme</term>
<term>Culture cellulaire</term>
<term>Dopa</term>
<term>Ascorbique acide</term>
<term>Neuroblastome</term>
<term>Antiparkinsonien</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>8</s2>
</fA05>
<fA06>
<s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>PARDO (B.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>MENA (M. A.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>FAHN (S.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>GARCIA DE YEBENES (J.)</s1>
</fA11>
<fA14 i1="01">
<s1>Cent. Ramón y Cajal', dep. res.</s1>
<s2>Madrid 28404</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA20>
<s1>278-284</s1>
</fA20>
<fA21>
<s1>1993</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000034697320040</s5>
</fA43>
<fA44>
<s0>0000</s0>
</fA44>
<fA45>
<s0>36 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>93-0595131</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X">
<s0>002B02B06</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Tumeur</s0>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Tumor</s0>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Tumor</s0>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Prévention</s0>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Prevention</s0>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Prevención</s0>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Toxicité</s0>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Toxicity</s0>
</fC03>
<fC03 i1="03" i2="X" l="GER">
<s0>Giftigkeit</s0>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Toxicidad</s0>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Homme</s0>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Human</s0>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Hombre</s0>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Culture cellulaire</s0>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Cell culture</s0>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Cultivo celular</s0>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Dopa</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Dopa</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Dopa</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Ascorbique acide</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Ascorbic acid</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Ascórbico ácido</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Neuroblastome</s0>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Neuroblastoma</s0>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Neuroblastoma</s0>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Antiparkinsonien</s0>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Antiparkinson agent</s0>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Antiparkinsoniano</s0>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
</fC07>
<fN21>
<s1>286</s1>
</fN21>
</pA>
</standard>
</inist>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Fahn, S" sort="Fahn, S" uniqKey="Fahn S" first="S." last="Fahn">S. Fahn</name>
<name sortKey="Garcia De Yebenes, J" sort="Garcia De Yebenes, J" uniqKey="Garcia De Yebenes J" first="J." last="Garcia De Yebenes">J. Garcia De Yebenes</name>
</noCountry>
<country name="États-Unis">
<noRegion>
<name sortKey="Pardo, B" sort="Pardo, B" uniqKey="Pardo B" first="B." last="Pardo">B. Pardo</name>
</noRegion>
<name sortKey="Mena, M A" sort="Mena, M A" uniqKey="Mena M" first="M. A." last="Mena">M. A. Mena</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003753 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 003753 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:93-0595131
   |texte=   Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024